Correlation Between HUMANA and Novozymes A/S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUMANA and Novozymes A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUMANA and Novozymes A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUMANA INC and Novozymes AS B, you can compare the effects of market volatilities on HUMANA and Novozymes A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUMANA with a short position of Novozymes A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUMANA and Novozymes A/S.

Diversification Opportunities for HUMANA and Novozymes A/S

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between HUMANA and Novozymes is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding HUMANA INC and Novozymes AS B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS B and HUMANA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUMANA INC are associated (or correlated) with Novozymes A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS B has no effect on the direction of HUMANA i.e., HUMANA and Novozymes A/S go up and down completely randomly.

Pair Corralation between HUMANA and Novozymes A/S

Assuming the 90 days trading horizon HUMANA INC is expected to under-perform the Novozymes A/S. But the bond apears to be less risky and, when comparing its historical volatility, HUMANA INC is 1.91 times less risky than Novozymes A/S. The bond trades about -0.21 of its potential returns per unit of risk. The Novozymes AS B is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest  6,199  in Novozymes AS B on August 31, 2024 and sell it today you would lose (319.00) from holding Novozymes AS B or give up 5.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

HUMANA INC  vs.  Novozymes AS B

 Performance 
       Timeline  
HUMANA INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUMANA INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for HUMANA INC investors.
Novozymes AS B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

HUMANA and Novozymes A/S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUMANA and Novozymes A/S

The main advantage of trading using opposite HUMANA and Novozymes A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUMANA position performs unexpectedly, Novozymes A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes A/S will offset losses from the drop in Novozymes A/S's long position.
The idea behind HUMANA INC and Novozymes AS B pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges